Jiangsu Recbio Technology Co Ltd Class H 02179
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 8.96
- Day Range
- HKD 8.75–9.10
- 52-Week Range
- HKD 7.95–14.58
- Bid/Ask
- HKD 8.61 / HKD 9.03
- Market Cap
- HKD 4.27 Bil
- Volume/Avg
- 6,500 / 16,884
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 472
- Website
- https://www.recbio.cn
Comparables
Valuation
Metric
|
02179
|
300841
|
688670
|
---|---|---|---|
Price/Earnings (Normalized) | — | 13.51 | 21.93 |
Price/Book Value | 4.75 | 2.25 | 1.50 |
Price/Sales | — | 4.99 | 51.06 |
Price/Cash Flow | — | 12.25 | 69.60 |
Price/Earnings
02179
300841
688670
Financial Strength
Metric
|
02179
|
300841
|
688670
|
---|---|---|---|
Quick Ratio | 3.86 | 4.14 | 1.40 |
Current Ratio | 3.99 | 4.49 | 3.34 |
Interest Coverage | −84.89 | 119.95 | −80.32 |
Quick Ratio
02179
300841
688670
Profitability
Metric
|
02179
|
300841
|
688670
|
---|---|---|---|
Return on Assets (Normalized) | −23.96% | — | −4.87% |
Return on Equity (Normalized) | −46.33% | — | −5.91% |
Return on Invested Capital (Normalized) | −30.73% | — | −5.65% |
Return on Assets
02179
300841
688670
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Tlxmrrsd | Nlktw | $605.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cpbgyzyg | Ngvmrl | $116.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bkkgmbnr | Jwrnv | $108.5 Bil | |
MRNA
| Moderna Inc | Mfzzqnzmv | Fdd | $62.9 Bil | |
BNTX
| BioNTech SE ADR | Lglgyhnx | Mnff | $23.9 Bil | |
ARGX
| argenx SE ADR | Qhsfrsn | Wttf | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zgrjjmb | Mhjsfg | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Lzwxwxvrj | Mskgln | $14.3 Bil | |
INCY
| Incyte Corp | Lxczrwzdh | Clgqdx | $12.9 Bil | |
UTHR
| United Therapeutics Corp | Vfqzlsdg | Yydw | $12.1 Bil |